News: September, 2009

Light The Night Event Downtown on Oct. 1

Friday, September 25th, 2009

BY: DAGNY STUART This year’s Light the Night Walk to benefit the Leukemia and Lymphoma Society is slated for Thursday, Oct. 1, at LP Field in downtown Nashville. This visually stunning event takes place at sunset, with participants carrying lighted balloons. White balloons are carried by cancer survivors, red balloons by supporters and gold balloons [...]

Jessen Lands American Cancer Society Research Award

Friday, September 25th, 2009

BY: MELISSA MARINO Jason Jessen, Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a four-year, $720,000 research scholar grant from the American Cancer Society. The “Research Scholar Grants in Basic, Preclinical, Clinical and Epidemiology Research” provide support for independent, self-directed researchers in the first six years of their independent research careers to [...]

Cancer Investigator Moses Wins Research Award

Monday, September 21st, 2009

Harold L. (Hal) Moses, M.D., professor of Cancer Biology, Medicine, and Pathology and director emeritus of  Vanderbilt-Ingram Comprehensive Cancer Center, has earned the Earl Sutherland Prize for Achievement in Research at Vanderbilt University. The award was announced at the Fall Faculty Assembly, September 1. The Earl Sutherland Prize for Achievement in Research is awarded annually [...]

Lung Cancer Trial Goes Online for ‘Never Smokers’

Friday, September 18th, 2009

By Dagny Stuart One of the enduring mysteries of lung cancer is why so many people who never smoked develop the disease. More than 219,000 people are diagnosed with lung cancer in the United States every year, according to the National Cancer Institute. About 20,000 — one in 10 — never smoked, and most are [...]

Writing Workshop for Cancer Survivors Starts Oct. 7

Wednesday, September 16th, 2009

A new program for cancer survivors who are interested in learning about expressive writing begins October 7.

VICC Expands Phase I Clinical Trials Program

Friday, September 11th, 2009

BY: DAGNY STUART Vanderbilt-Ingram Cancer Center is expanding its Phase I Drug Development Program with newly dedicated clinical space and new leadership. Jordan Berlin, M.D., associate professor of Medicine, has been named director of the Phase I cancer research program and Igor Puzanov, M.D., assistant professor of Medicine, has been named associate director. Berlin currently [...]

Device to Give Peek into Protein Structures

Friday, September 11th, 2009

BY: BILL SNYDER Vanderbilt University researchers have received a $3.9 million federal stimulus grant to purchase a powerful analytical instrument that will greatly accelerate their studies of complex protein structures. The ultra-high field, 900 megahertz nuclear magnetic resonance (NMR) spectrometer is a much more powerful version of instruments that have been used for years to [...]

VU Joins Effort To Develop New Cancer Therapies

Friday, September 4th, 2009

BY: MELISSA MARINO Vanderbilt University has been selected as one of 10 centers in the nation to participate in the Chemical Biology Consortium (CBC), a major new initiative to facilitate the discovery and development of new agents to treat cancer. As one of four Chemical Diversity Centers, Vanderbilt’s role in the consortium will be to [...]